289 related articles for article (PubMed ID: 32888342)
1. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
[TBL] [Abstract][Full Text] [Related]
2. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
Zhang L; San Valentin EMD; John TM; Jenq RR; Do KA; Hanna EY; Peterson CB; Reyes-Gibby CC
Cancer; 2024 Jan; 130(1):150-161. PubMed ID: 37688396
[TBL] [Abstract][Full Text] [Related]
3. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer.
Vesty A; Gear K; Biswas K; Mackenzie BW; Taylor MW; Douglas RG
Support Care Cancer; 2020 Jun; 28(6):2683-2691. PubMed ID: 31650293
[TBL] [Abstract][Full Text] [Related]
4. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.
Hayes RB; Ahn J; Fan X; Peters BA; Ma Y; Yang L; Agalliu I; Burk RD; Ganly I; Purdue MP; Freedman ND; Gapstur SM; Pei Z
JAMA Oncol; 2018 Mar; 4(3):358-365. PubMed ID: 29327043
[TBL] [Abstract][Full Text] [Related]
5. Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma.
Kumpitsch C; Moissl-Eichinger C; Pock J; Thurnher D; Wolf A
Sci Rep; 2020 Oct; 10(1):16582. PubMed ID: 33024215
[TBL] [Abstract][Full Text] [Related]
6. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study.
Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H
Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434
[TBL] [Abstract][Full Text] [Related]
7. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
8. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
[TBL] [Abstract][Full Text] [Related]
9. Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.
San Valentin EMD; Do KA; Yeung SJ; Reyes-Gibby CC
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069314
[TBL] [Abstract][Full Text] [Related]
10. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
11. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy.
Hou J; Zheng H; Li P; Liu H; Zhou H; Yang X
Radiother Oncol; 2018 Oct; 129(1):44-51. PubMed ID: 29735410
[TBL] [Abstract][Full Text] [Related]
12. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
[TBL] [Abstract][Full Text] [Related]
13. Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature.
Shin JM; Luo T; Kamarajan P; Fenno JC; Rickard AH; Kapila YL
Sci Rep; 2017 Aug; 7(1):9934. PubMed ID: 28855542
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
[TBL] [Abstract][Full Text] [Related]
15. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
16. 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment.
Guerrero-Preston R; Godoy-Vitorino F; Jedlicka A; Rodríguez-Hilario A; González H; Bondy J; Lawson F; Folawiyo O; Michailidi C; Dziedzic A; Thangavel R; Hadar T; Noordhuis MG; Westra W; Koch W; Sidransky D
Oncotarget; 2016 Aug; 7(32):51320-51334. PubMed ID: 27259999
[TBL] [Abstract][Full Text] [Related]
17. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
[TBL] [Abstract][Full Text] [Related]
18. Oral Microbiome Profiling in Smokers with and without Head and Neck Cancer Reveals Variations Between Health and Disease.
Sharma AK; DeBusk WT; Stepanov I; Gomez A; Khariwala SS
Cancer Prev Res (Phila); 2020 May; 13(5):463-474. PubMed ID: 32071121
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.
Correia AV; Coêlho MR; de Oliveira Mendes Cahú GG; de Almeida Silva JL; da Mota Vasconcelos Brasil C; de Castro JF
Support Care Cancer; 2015 Jul; 23(7):2105-11. PubMed ID: 25547479
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
